Role of Uttarbasti in the Management of Mutra Marga Sankoch (Urethral Stricture)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00535717|
Recruitment Status : Completed
First Posted : September 26, 2007
Last Update Posted : September 26, 2007
Uttarbasti is per urethral administration of medicated oil which has been recommended by Sushrut for urinary track disorders.
As far as conventional surgery is concerned urethral stricture still remains a challenge due to post procedural high recurrences and complications
Uttarbasti being almost non invasive, with minimum recurrences and most economical, easy to practice OPD procedure, can be the treatment of choice in the management of urethral stricture.
|Condition or disease||Intervention/treatment||Phase|
|Urethral Stricture||Procedure: uttarbasti (per urethral administration of medicated oil )||Phase 2|
|Study Type :||Interventional (Clinical Trial)|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Role of Uttarbasti in the Management of Mutra Marga Sankoch (Urethral Stricture)|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00535717
|Principal Investigator:||Rajendra H Amilkanthwar, M.D.(Ayu.)||Maharashtra university of health sciences, Nashik (INDIA)|